Albert David Ltd. is currently positioned in a challenging space with stagnant growth, but comparisons with its peers reveal several outperformers, especially in profitability and growth metrics. Companies like Mankind Pharma and Dr. Reddy's show strong potential. While Albert David has low valuations, it lacks growth and profitability metrics, making it less attractive.

• • Albert David Ltd. shows zero revenue growth and profitability metrics, indicating stagnation.
• • Mankind Pharma and Dr. Reddy's Laboratories lead in profitability and growth metrics among peers.
• • Sun Pharma appears overvalued with a high PE ratio despite decent growth.